Ocimum Biosolutions this week introduced a range of microRNA microarray kits and assays including human, mouse, rat, and other systems on its OciChip platform.
The epoxide-coated microarray slides are spotted with probes that target the miRNAs available in the latest release of mirBase as well as putative miRNAs, according to the Hyderabad, India-based firm. Ocimum said it also now offers customized miRNA chips and services.
Aushon Biosystems last week launched multiplex biomarker panels for the quantification of eight biomarkers related to drug-induced kidney damage in humans. The new panels include eight markers: KIM-1, clusterin, TIMP-1, VEGF, trefoil factor-3, osteopontin, EGF, and NGAL.
Billerica, Mass.-based Aushon said that the new products are based on recent studies that identified biomarkers for kidney injury during pre-clinical testing for certain drugs. The Human Nephrotoxicity Panels can be used to identify and quantify renal toxicity biomarkers to assist in determining risk, Aushon said.
All panels were validated for use with urine samples and are based on Aushon's SearchLight protein array technology, a multiplex, sandwich enzyme-linked immunosorbent assay system based on the chemiluminescent or infrared detection of analytes. Researchers can analyze samples from clinical trials using Aushon's sample-testing service or conduct the analysis themselves using the firm's chemiluminescent biomarker kits and imaging system, the company said.